Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:05 PM
Ignite Modification Date:
2025-12-24 @ 2:05 PM
NCT ID:
NCT06752395
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Obtained written informed consent
* Subjects having \<30mm nodule on computed tomography
* Subjects without contraindication to brochoscopy
Exclusion Criteria:
* Patients with central lesions that can be visually confirmed by bronchoscopy or those with suspicious findings of cancer metastasis in the mediastinal lymph nodes, who do not require radial bronchial endoscopic ultrasound (RP-EBUS).
* Patients who cannot discontinue medications that increase bleeding risk, such as antiplatelet agents or anticoagulants.
* Patients with bleeding disorders (e.g., platelet count \< 100,000/mm³).
* Patients with severe comorbidities (e.g., serious respiratory or cardiovascular diseases) that make bronchoscopy unsafe.
* Patients with hypersensitivity or allergies to drugs commonly used in endoscopic procedures, including lidocaine, midazolam, fentanyl, or flumazenil.
* Pregnant or breastfeeding patients.
* Patients with confirmed lung cancer undergoing rebiopsy for genetic testing or other purposes.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06752395
Study Brief:
Protocol Section:
NCT06752395